MedPath

Study of effect of dermaroller with vitamin c serum application for treatment of darkened facsial ski

Phase 3
Conditions
Health Condition 1: L811- ChloasmaHealth Condition 2: L814- Other melanin hyperpigmentation
Registration Number
CTRI/2019/05/019327
Lead Sponsor
Alisha Mittal
Brief Summary

Not available

Detailed Description

Not available

Recruitment & Eligibility

Status
ot Yet Recruiting
Sex
Not specified
Target Recruitment
0
Inclusion Criteria

1) All patients of mixed and epidermal melasma reporting to OPD.

2) Patient willing to participate and have signed the informed consent

3)Patients who are on no concurrent systemic or topical treatment for melasma.

Exclusion Criteria

1)Patients with dermal melasma

2)Patients with fever or signs of any systemic or local inflammation or infection.

3)Inability to come for regular follow-ups.

4)Patients not willing to participate in the study

5)Moderate to severe chronic skin disease such as eczema and psoriasis

6)Blood dyscrasias, patients on anticoagulant therapy

7)Extreme keloidal tendency

8)Patient on chemo/radiotherapy

Study & Design

Study Type
Interventional
Study Design
Not specified
Primary Outcome Measures
NameTimeMethod
Improvment in Melasma Area Severity Index scoreTimepoint: 3 months
Secondary Outcome Measures
NameTimeMethod
Any effect on quality of lifeTimepoint: 3 Months
© Copyright 2025. All Rights Reserved by MedPath